These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 33355184)

  • 1. BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression.
    Alpsoy A; Utturkar SM; Carter BC; Dhiman A; Torregrosa-Allen SE; Currie MP; Elzey BD; Dykhuizen EC
    Cancer Res; 2021 Feb; 81(4):820-833. PubMed ID: 33355184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.
    Alpsoy A; Dykhuizen EC
    J Biol Chem; 2018 Mar; 293(11):3892-3903. PubMed ID: 29374058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-canonical BRD9-containing BAF chromatin remodeling complex regulates naive pluripotency in mouse embryonic stem cells.
    Gatchalian J; Malik S; Ho J; Lee DS; Kelso TWR; Shokhirev MN; Dixon JR; Hargreaves DC
    Nat Commun; 2018 Dec; 9(1):5139. PubMed ID: 30510198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
    Link KA; Balasubramaniam S; Sharma A; Comstock CE; Godoy-Tundidor S; Powers N; Cao KH; Haelens A; Claessens F; Revelo MP; Knudsen KE
    Cancer Res; 2008 Jun; 68(12):4551-8. PubMed ID: 18559499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation.
    Michel BC; D'Avino AR; Cassel SH; Mashtalir N; McKenzie ZM; McBride MJ; Valencia AM; Zhou Q; Bocker M; Soares LMM; Pan J; Remillard DI; Lareau CA; Zullow HJ; Fortoul N; Gray NS; Bradner JE; Chan HM; Kadoch C
    Nat Cell Biol; 2018 Dec; 20(12):1410-1420. PubMed ID: 30397315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors.
    Wang X; Wang S; Troisi EC; Howard TP; Haswell JR; Wolf BK; Hawk WH; Ramos P; Oberlick EM; Tzvetkov EP; Ross A; Vazquez F; Hahn WC; Park PJ; Roberts CWM
    Nat Commun; 2019 Apr; 10(1):1881. PubMed ID: 31015438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.
    Takayama K; Horie-Inoue K; Suzuki T; Urano T; Ikeda K; Fujimura T; Takahashi S; Homma Y; Ouchi Y; Inoue S
    Mol Endocrinol; 2012 May; 26(5):748-61. PubMed ID: 22456197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolically stable diphenylamine derivatives suppress androgen receptor and BET protein in prostate cancer.
    Yu J; Zhou P; Du W; Xu R; Yan G; Deng Y; Li X; Chen Y
    Biochem Pharmacol; 2020 Jul; 177():113946. PubMed ID: 32247852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Modulation of Polycomb-Associated Histone Marks by cBAF, pBAF, and gBAF Complexes.
    Bergwell M; Park J; Kirkland JG
    bioRxiv; 2024 Jan; ():. PubMed ID: 37790495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state.
    Xiao M; Kondo S; Nomura M; Kato S; Nishimura K; Zang W; Zhang Y; Akashi T; Viny A; Shigehiro T; Ikawa T; Yamazaki H; Fukumoto M; Tanaka A; Hayashi Y; Koike Y; Aoyama Y; Ito H; Nishikawa H; Kitamura T; Kanai A; Yokoyama A; Fujiwara T; Goyama S; Noguchi H; Lee SC; Toyoda A; Hinohara K; Abdel-Wahab O; Inoue D
    Nat Commun; 2023 Dec; 14(1):8372. PubMed ID: 38102116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
    Isikbay M; Otto K; Kregel S; Kach J; Cai Y; Vander Griend DJ; Conzen SD; Szmulewitz RZ
    Horm Cancer; 2014 Apr; 5(2):72-89. PubMed ID: 24615402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Value of
    Barma N; Stone TC; Carmona Echeverria LM; Heavey S
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
    Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
    Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.
    Nguyen VT; Tessema M; Weissman BE
    Cancer Treat Res; 2023; 190():211-244. PubMed ID: 38113003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential requirements for different subfamilies of the mammalian SWI/SNF chromatin remodeling enzymes in myoblast cell cycle progression and expression of the Pax7 regulator.
    Padilla-Benavides T; Olea-Flores M; Nshanji Y; Maung MT; Syed SA; Imbalzano AN
    Biochim Biophys Acta Gene Regul Mech; 2022 Feb; 1865(2):194801. PubMed ID: 35217218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Genome-wide CRISPR Screen Reveals a Role for the Non-canonical Nucleosome-Remodeling BAF Complex in Foxp3 Expression and Regulatory T Cell Function.
    Loo CS; Gatchalian J; Liang Y; Leblanc M; Xie M; Ho J; Venkatraghavan B; Hargreaves DC; Zheng Y
    Immunity; 2020 Jul; 53(1):143-157.e8. PubMed ID: 32640256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation.
    Lallous N; Leblanc E; Munuganti RS; Hassona MD; Nakouzi NA; Awrey S; Morin H; Roshan-Moniri M; Singh K; Lawn S; Yamazaki T; Adomat HH; Andre C; Daugaard M; Young RN; Guns ES; Rennie PS; Cherkasov A
    Mol Cancer Ther; 2016 Dec; 15(12):2936-2945. PubMed ID: 27765852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.
    Middeljans E; Wan X; Jansen PW; Sharma V; Stunnenberg HG; Logie C
    PLoS One; 2012; 7(3):e33834. PubMed ID: 22442726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.
    Kregel S; Kiriluk KJ; Rosen AM; Cai Y; Reyes EE; Otto KB; Tom W; Paner GP; Szmulewitz RZ; Vander Griend DJ
    PLoS One; 2013; 8(1):e53701. PubMed ID: 23326489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes.
    Huang CY; Beliakoff J; Li X; Lee J; Li X; Sharma M; Lim B; Sun Z
    Mol Endocrinol; 2005 Dec; 19(12):2915-29. PubMed ID: 16051670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.